Semi-Annual Consolidated Balance Sheet

JCR Pharmaceuticals Co.,Ltd. - Filing #7295903

Concept As at
2024-09-30
As at
2024-03-31
Semi-annual consolidated balance sheet
Balance sheet
Assets
Current assets
Cash and deposits
18,271,000,000 JPY
18,756,000,000 JPY
Other
2,915,000,000 JPY
2,955,000,000 JPY
Current assets
56,307,000,000 JPY
57,581,000,000 JPY
Non-current assets
Property, plant and equipment
31,754,000,000 JPY
30,040,000,000 JPY
Property, plant and equipment
Buildings and structures
Buildings and structures, net
13,681,000,000 JPY
14,140,000,000 JPY
Land
10,587,000,000 JPY
10,587,000,000 JPY
Construction in progress
2,912,000,000 JPY
171,000,000 JPY
Other
Other, net
4,572,000,000 JPY
5,141,000,000 JPY
Intangible assets
Other
1,228,000,000 JPY
1,338,000,000 JPY
Intangible assets
3,247,000,000 JPY
3,496,000,000 JPY
Investments and other assets
13,312,000,000 JPY
11,107,000,000 JPY
Investments and other assets
Investment securities
12,084,000,000 JPY
9,120,000,000 JPY
Other
1,232,000,000 JPY
1,991,000,000 JPY
Allowance for doubtful accounts
-4,000,000 JPY
-4,000,000 JPY
Non-current assets
48,314,000,000 JPY
44,644,000,000 JPY
Assets
104,622,000,000 JPY
102,226,000,000 JPY
Liabilities
Current liabilities
Short-term borrowings
16,262,000,000 JPY
8,950,000,000 JPY
Income taxes payable
122,000,000 JPY
1,657,000,000 JPY
Other
3,969,000,000 JPY
5,510,000,000 JPY
Current liabilities
34,133,000,000 JPY
30,135,000,000 JPY
Non-current liabilities
Long-term borrowings
12,150,000,000 JPY
14,350,000,000 JPY
Retirement benefit liability
931,000,000 JPY
903,000,000 JPY
Other
261,000,000 JPY
280,000,000 JPY
Non-current liabilities
13,438,000,000 JPY
15,615,000,000 JPY
Liabilities
47,572,000,000 JPY
45,750,000,000 JPY
Provision for bonuses
1,178,000,000 JPY
1,016,000,000 JPY
Provision for bonuses for directors (and other officers)
63,000,000 JPY
114,000,000 JPY
Net assets
Share capital
9,061,000,000 JPY
9,061,000,000 JPY
Shareholders' equity
Capital surplus
10,392,000,000 JPY
10,384,000,000 JPY
Retained earnings
36,517,000,000 JPY
37,278,000,000 JPY
Treasury shares
-2,542,000,000 JPY
-2,963,000,000 JPY
Shareholders' equity
53,429,000,000 JPY
53,761,000,000 JPY
Valuation and translation adjustments
Valuation difference on available-for-sale securities
2,604,000,000 JPY
741,000,000 JPY
Deferred gains or losses on hedges
7,000,000 JPY
0 JPY
Foreign currency translation adjustment
466,000,000 JPY
731,000,000 JPY
Remeasurements of defined benefit plans
120,000,000 JPY
132,000,000 JPY
Valuation and translation adjustments
3,199,000,000 JPY
1,604,000,000 JPY
Share acquisition rights
75,000,000 JPY
812,000,000 JPY
Non-controlling interests
345,000,000 JPY
297,000,000 JPY
Net assets
57,049,000,000 JPY
56,475,000,000 JPY
Liabilities and net assets
104,622,000,000 JPY
102,226,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.